National Ovarian Cancer Awareness Month: Increasing the Public’s Knowledge About the Disease
September marks National Ovarian Cancer Awareness Month, a crucial period dedicated to raising public awareness about one of the deadliest cancers affecting women. The primary objective of this month-long campaign is to educate the public about ovarian cancer, its symptoms, risk factors, and the importance of early detection. The Gynecologic Cancer Center of Excellence (GYN-COE) at Walter Reed stands at the forefront of this battle, offering comprehensive and precision oncology services for gynecologic malignancies. By collaborating with other leading cancer centers, GYN-COE provides patients with access to cutting-edge clinical trials, aiming to improve treatment outcomes and ultimately save lives.
Lt. Col. (Dr.) Christopher Tarney, a gynecologic oncologist and associate program director at Walter Reed, along with his colleagues Lt. Col. (Dr.) Kristen Bunch and Maj. (Dr.) Susan Folsom, are deeply committed to advancing the fight against ovarian cancer. They emphasize that early detection is the key to improving survival rates. According to the Centers for Disease Control and Prevention (CDC), ovarian cancer is the deadliest cancer of the female reproductive system and the second most common gynecologic cancer in the United States. Globally, over 300,000 cases of ovarian cancer are diagnosed annually, resulting in approximately 200,000 deaths. The high mortality rate is largely due to the disease’s insidious nature, often presenting at advanced stages when treatment options are limited.
Research into the causes and progression of ovarian cancer is ongoing, with scientists striving to uncover the mechanisms behind its development and spread. Evidence suggests that ovarian cancer may originate from abnormal cells in the fallopian tubes, challenging the traditional belief that it begins in the ovaries themselves. Genetic factors also play a significant role, with approximately 20% of ovarian cancers being heritable through genetic mutations. The BRCA1 and BRCA2 genes are the most well-known culprits, and a family history of ovarian cancer remains the most significant risk factor for developing the disease. Other risk factors include inherited gene changes, hormone use, smoking, obesity, and certain aspects of reproductive health history.
Despite the challenges in detecting ovarian cancer early, there are screening methods available that can help identify the disease in its nascent stages. Symptoms of ovarian cancer are often nonspecific and can easily be mistaken for less serious conditions. These symptoms include abdominal bloating, a feeling of fullness, early satiety, pelvic pain, and fatigue. Preventative measures such as genetic testing, risk-reducing surgery, and breastfeeding can also play a role in reducing the risk of developing ovarian cancer. Treatment typically involves a combination of chemotherapy and surgery, with the aim of removing as much of the cancerous tissue as possible and preventing recurrence.
The White House has issued a proclamation for National Ovarian Cancer Awareness Month, urging increased awareness and support for those affected by the disease. This official recognition underscores the importance of education and advocacy in the fight against ovarian cancer. The GYN-COE at Walter Reed remains a vital resource for information and support, providing patients and their families with the tools they need to navigate their cancer journey. By fostering a greater understanding of ovarian cancer, we can empower individuals to take proactive steps in managing their health and potentially save lives.
In the spirit of National Ovarian Cancer Awareness Month, two local survivors, Kathy Ventre and Dianne Weidman, are sharing their personal stories to highlight the early warning signs of ovarian cancer. Ventre describes ovarian cancer not as a silent disease but one that ‘whispers,’ urging women to listen to their bodies and seek medical advice if something feels amiss. She recounts her experience of feeling like she was about to ovulate, only to discover a large mass on her left ovary. Both Ventre and Weidman are now cancer-free, but their journeys have been fraught with challenges. Weidman has survived four rounds of ovarian cancer, enduring 24 months of chemotherapy, four surgeries, and losing her hair three times.
Ventre and Weidman emphasize the importance of remembering the ‘beat’ acronym for ovarian cancer: bloating, eating difficulties, abdominal or pelvic pain, and trouble with urination or frequency. They remind us that ovarian cancer affects not just women but also the supportive men in their lives. With a strong support system, both women are dedicated to raising awareness and funds for ovarian cancer research. Their experiences have given them a new lease on life, and they are determined to use their voices to help others. Events like the Teal Power Run and Walk at Summit Park in Blue Ash serve as platforms to raise awareness and funds, bringing communities together in the fight against ovarian cancer.
Ovarian cancer is a disease that can often be caught in its early stages with proper awareness and education. Ventre and Weidman stress that early detection is crucial in combating ovarian cancer. The subtlety of its symptoms means that many women may overlook or dismiss them, which is why paying close attention to any changes in the body is vital. The ‘beat’ acronym serves as a helpful reminder of the common symptoms, encouraging women to seek medical advice if they experience any of these signs. By extending their support and encouragement to others, Ventre and Weidman hope to inspire those going through similar experiences and underscore the importance of a robust support network in battling cancer.
As autumn ushers in cooler weather and seasonal festivities, it also brings a heightened focus on advocacy and awareness for ovarian and prostate cancer. These health campaigns, although targeting different demographics, share a common goal: to educate the public and promote early detection. The ‘Gift of Life’ program exemplifies this mission by empowering women to recognize and address symptoms of ovarian cancer. Through events like the Julie Richardson Procter 5k Ribbon Run Monster Dash, the program honors those who have fought ovarian cancer and continues to inspire others. Additionally, the program provides free PSA screenings for at-risk men, addressing the critical need for early detection in prostate cancer, particularly among Black men who face higher risks.
Healthcare disparities remain a significant challenge in the fight against cancer. Despite advancements in diagnostics and treatment, access to care is not always equitable. The ‘Gift of Life’ program’s efforts to provide free screenings and additional healthcare services highlight the importance of making these resources available to all. By educating the public and facilitating access to screenings, the program aims to reduce the incidence and mortality rates of ovarian and prostate cancer. As we enjoy the autumn season, it’s essential to remember those currently battling these diseases and honor the memories of those we have lost. Their stories serve as a beacon, guiding us toward a future where early detection and effective treatment are accessible to everyone.
Understanding the genetic factors associated with ovarian cancer is another critical aspect of prevention and early detection. Up to 25% of ovarian cancer cases are linked to inherited genetic mutations, as noted by the American Cancer Society. Dr. Melissa Frey, a gynecologic oncologist at NewYork-Presbyterian/Weill Cornell Medical Center, highlights the growing number of strategies to prevent and detect ovarian cancer in high-risk individuals. Genetic testing plays a pivotal role in identifying those at increased risk, offering them the opportunity to take preventative measures. Without a reliable screening test for ovarian cancer, genetic testing becomes even more crucial in catching the disease early when it is more treatable.
Individuals diagnosed with ovarian cancer, as well as their first and second-degree relatives, should consider undergoing genetic testing. This process can provide invaluable insights into the nature of the cancer and guide treatment decisions. Moreover, genetic testing alerts family members to their potential risk, enabling them to take preventative actions. Those who test positive for genetic mutations linked to ovarian cancer should consult with a genetic specialist to develop a personalized care plan. Surgical removal of the fallopian tubes and ovaries is the most effective way to reduce the risk, although birth control pills can also lower the risk while potentially increasing the risk of breast cancer.
The Genetics and Personalized Cancer Prevention Program at Weill Cornell Medicine offers comprehensive genetic screening, counseling, and treatment strategies for individuals with hereditary cancer risk. This program provides long-term, multidisciplinary care and support for patients and their families, emphasizing the importance of sharing a cancer diagnosis with relatives to help them understand their risk and take preventative measures. Genetic testing is a straightforward, one-time procedure that can be done through a blood or saliva sample. Individuals should feel empowered to discuss their need for genetic testing with their healthcare providers, taking proactive steps to safeguard their health and that of their loved ones.
As we conclude our discussion on National Ovarian Cancer Awareness Month, it’s evident that education, early detection, and genetic testing are vital components in the fight against this devastating disease. By raising awareness and providing access to necessary resources, we can make significant strides in reducing the incidence and mortality rates of ovarian cancer. The stories of survivors like Kathy Ventre and Dianne Weidman, along with the efforts of programs like ‘Gift of Life’ and institutions like the GYN-COE at Walter Reed, inspire us to continue advocating for better healthcare and support for those affected by ovarian cancer. Let us use this month as an opportunity to honor the resilience of survivors, remember those we have lost, and commit to a future where ovarian cancer is detected early and treated effectively.